Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ascletis Pharma Inc (1672 HK)
Watchlist
67
Analysis
Health Care
•
China
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Ascletis Pharma Inc
•
16 Jul 2018 13:36
Ascletis Pharma (歌礼制药) IPO: Emerging Player in the Crowded HCV Drug Market
Ascletis Pharma, a China-based biotechnology company, is raising up to USD 300 million to listing on the Hong Kong Stock Exchange. Ascletis is the...
Ke Yan, CFA, FRM
Follow
636 Views
Share
First
Previous
11
12
13
14
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x